Author:
Gilsenan Alicia,Fortuny Joan,Cainzos-Achirica Miguel,Cantero Oscar F.,Flynn Robert W. V.,Garcia-Rodriguez Luis,Harding Abenah,Kollhorst Bianca,Karlsson Pär,Linnér Love,MacDonald Thomas M.,Odsbu Ingvild,Plana Estel,Ruigómez Ana,Schink Tania,Ziemiecki Ryan,Andrews Elizabeth B.
Funder
Shire Pharmaceuticals, now part of the Takeda group of companies
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference15 articles.
1. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23(5):461–76.
2. Wald A, Scarpignato C, Kamm MA, Mueller-Lissner S, Helfrich I, Schuijt C, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther. 2007;26(2):227–36.
3. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132(1):397–414.
4. Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35(7):745–67.
5. FDA. FDA briefing document, New Drug Application 210166 for prucalopride: Gastrointestinal Drug Advisory Committee meeting. 18 October 2018. Available from:
https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM623493.pdf
. Accessed 26 Oct 2018.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献